Clinical Trial: Prenatal Examination of Deletion 22q11 Syndrome : Thymic Dysgenesis THYMI Study

Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Observational




Official Title: Research of Thymix Dysgenesis in Prenatal Examination of Deletion 22q11 Syndrome

Brief Summary: 22q11.2 microdeletion seems the prenatally under-diagnosed . Indeed , there is a mismatch between the series on the heart rate of 22q11.2 antenatal 84% against 30% in the adult series despite a perinatal mortality of 16% suggesting opportunities for improvement in the prenatal diagnosis of fetus with a microdeletion 22q11.2 , especially without heart disease